Compounds in Boswellia extract have been shown to bind directly to 5-LOX, an enzyme that transforms fatty acids into inflammatory factors like leukotriene B4.. A compound in boswellia called AKBA is the key to this beneficial action. Each 100 mg vegetarian capsule of 5-LOX Inhibitor with AprèsFlex® is standardized to provide 20% of active AKBA from boswellia.

AprèsFlex® absorbs 52% more than standard boswellia extract and is standardized for the active AKBA compound.

5-LOX Inhibitor with AprèsFlex® Benefits

• Made with standardized Boswellia serrata extract
• Promotes a healthy inflammatory response by inhibiting 5-LOX enzyme
• Supports joint health, arterial health & healthy cell division